• Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

OrganoClick AB: RESOLUTIONS AT ORGANOCLICK'S ANNUAL GENERAL MEETING 2020

ORGCRegulatoriskt pressmeddelande2020-05-07 21:30
Läs börsmeddelandet

OrganoClick AB (publ) held its Annual General Meeting, 7 May 2020 at the company's head office in Täby where the following resolutions were adopted:

  • It was resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet.
  • It was resolved that the accumulated result was brought forward and balanced in the new accounts according with the proposal of the Board.
  • It was resolved to approve discharge from personal liability for the members of the Board of Directors and the CEO for their administration.
  • It was resolved that the Board of Directors will have five ordinary board members.
  • It was resolved in accordance with the nomination committee's proposal to pay a fixed fee of SEK 400.000 to the Chairman of the Board and a fixed fee of SEK 100.000 to the other ordinary members of the Board, in total a fee of SEK 800.000 to the Board, and that the Auditors' fee's will be paid in accordance with current approved invoicing.
  • It was resolved in accordance with the nomination committees proposal to re-elect Jan Johansson, Håkan Gustavson and Claes-Göran Beckeman, and new elect Charlotte Karlberg and Malin Bugge as board members. In accordance with the nomination committees proposal, Jan Johansson was re-elected as Chairman of the Board.
  • It was resolved in accordance with the nomination committees proposal to new-elect PricewaterhouseCoopers AB Deloitte AB as auditors until the annual general meeting 2022, with authorized public accountant Sebastian Ionescu as auditor in charge.
  • It was resolved to adopt the nomination procedure and election of nomination committee according to the proposal in the notice to the annual general meeting.
  • Notice was given that the Board had withdrawn the proposal of authorisation for the board of new issues of shares (point 17 in the Summons to the AGM). 
  • Notice was given that the nomination committee thanked Armando Córdova for his time as a board member during 2006-2020 and for his valuable work for the company.
  • Notice was given that the nomination committee thanked Deloitte AB with authorized public accountant Therese Kjellberg as auditor in charge for their good work during 2015-2020.

Due to the situation with Covid-19, the CEO did not held the ordinary presentation, but the company will publish a pre-recorded presentation, were the previous years activities and the result are presented and an outlook for 2020 on the company's webpage.

OrganoClick AB (publ)

The Board of Directors